Literature DB >> 18594793

Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis.

Stephen Trzeciak1, Jonathan V McCoy, R Phillip Dellinger, Ryan C Arnold, Michael Rizzuto, Nicole L Abate, Nathan I Shapiro, Joseph E Parrillo, Steven M Hollenberg.   

Abstract

OBJECTIVE: Sepsis mortality is closely linked to multi-organ failure, and impaired microcirculatory blood flow is thought to be pivotal in the pathogenesis of sepsis-induced organ failure. We hypothesized that changes in microcirculatory flow during resuscitation are associated with changes in organ failure over the first 24 h of sepsis therapy.
DESIGN: Prospective observational study.
SETTING: Emergency Department and Intensive Care Unit. PARTICIPANTS: Septic patients with systolic blood pressure <90 mmHg despite intravenous fluids or lactate >or=4.0 mM/L treated with early goal-directed therapy (EGDT). MEASUREMENTS AND
RESULTS: We performed Sidestream Dark Field (SDF) videomicroscopy of the sublingual microcirculation <3 h from EGDT initiation and again within a 3-6 h time window after initial. We imaged five sites and determined the mean microcirculatory flow index (MFI) (0 no flow to 3 normal) blinded to all clinical data. We calculated the Sequential Organ Failure Assessment (SOFA) score at 0 and 24 h, and defined improved SOFA a priori as a decrease >or=2 points. Of 33 subjects; 48% improved SOFA over 0-24 h. Age, APACHE II, and global hemodynamics did not differ significantly between organ failure groups. Among SOFA improvers, 88% increased MFI during EGDT, compared to 47% for non-improvers (P = 0.03). Median change in MFI was 0.23 for SOFA improvers versus -0.05 for non-improvers (P = 0.04).
CONCLUSIONS: Increased microcirculatory flow during resuscitation was associated with reduced organ failure at 24 h without substantial differences in global hemodynamics. These data support the hypothesis that targeting the microcirculation distinct from the macrocirculation could potentially improve organ failure in sepsis.

Entities:  

Mesh:

Year:  2008        PMID: 18594793      PMCID: PMC2821162          DOI: 10.1007/s00134-008-1193-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   41.787


  30 in total

1.  Orthogonal polarization spectral imaging: a new method for study of the microcirculation.

Authors:  W Groner; J W Winkelman; A G Harris; C Ince; G J Bouma; K Messmer; R G Nadeau
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

2.  Early goal-directed therapy in the treatment of severe sepsis and septic shock.

Authors:  E Rivers; B Nguyen; S Havstad; J Ressler; A Muzzin; B Knoblich; E Peterson; M Tomlanovich
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

3.  Effect of a maldistribution of microvascular blood flow on capillary O(2) extraction in sepsis.

Authors:  Christopher G Ellis; Ryon M Bateman; Michael D Sharpe; William J Sibbald; Ravi Gill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-01       Impact factor: 4.733

4.  Microvascular blood flow is altered in patients with sepsis.

Authors:  Daniel De Backer; Jacques Creteur; Jean-Charles Preiser; Marc-Jacques Dubois; Jean-Louis Vincent
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

5.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

6.  The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection.

Authors:  Nathan Shapiro; Michael D Howell; David W Bates; Derek C Angus; Long Ngo; Daniel Talmor
Journal:  Ann Emerg Med       Date:  2006-11       Impact factor: 5.721

7.  Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock.

Authors:  M H Weil; Y Nakagawa; W Tang; Y Sato; F Ercoli; R Finegan; G Grayman; J Bisera
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

8.  Nitroglycerin in septic shock after intravascular volume resuscitation.

Authors:  Peter E Spronk; Can Ince; Martin J Gardien; Keshen R Mathura; Heleen M Oudemans-van Straaten; Durk F Zandstra
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 9.  Endpoints in sepsis trials: more than just 28-day mortality?

Authors:  Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2004-05       Impact factor: 7.598

10.  How to evaluate the microcirculation: report of a round table conference.

Authors:  Daniel De Backer; Steven Hollenberg; Christiaan Boerma; Peter Goedhart; Gustavo Büchele; Gustavo Ospina-Tascon; Iwan Dobbe; Can Ince
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  132 in total

1.  Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients.

Authors:  Julien Pottecher; Stéphane Deruddre; Jean-Louis Teboul; Jean-François Georger; Christian Laplace; Dan Benhamou; Eric Vicaut; Jacques Duranteau
Journal:  Intensive Care Med       Date:  2010-08-20       Impact factor: 17.440

2.  Think locally: evaluation of the microcirculation in sepsis.

Authors:  Steve M Hollenberg
Journal:  Intensive Care Med       Date:  2010-08-20       Impact factor: 17.440

3.  Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.

Authors:  Christian Jung; Georg Fuernau; Suzanne de Waha; Ingo Eitel; Steffen Desch; Gerhard Schuler; Hans R Figulla; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2015-02-27       Impact factor: 5.460

4.  Microcirculation and multi-organ failure in patients with sepsis.

Authors:  C A den Uil; W K Lagrand; J J Brugts; P E Spronk
Journal:  Intensive Care Med       Date:  2008-09-24       Impact factor: 17.440

5.  A novel fluid resuscitation protocol: provide more protection on acute kidney injury during septic shock in rats.

Authors:  Wei Liu; Xue-Song Dong; Yu-Qiang Sun; Zhi Liu
Journal:  Int J Clin Exp Med       Date:  2014-04-15

6.  Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.

Authors:  Andrea Morelli; Abele Donati; Christian Ertmer; Sebastian Rehberg; Alessandra Orecchioni; Alessandro Di Russo; Paolo Pelaia; Paolo Pietropaoli; Martin Westphal
Journal:  Intensive Care Med       Date:  2011-02-19       Impact factor: 17.440

7.  Effects of fluids on microvascular perfusion in patients with severe sepsis.

Authors:  Gustavo Ospina-Tascon; Ana Paula Neves; Giovanna Occhipinti; Katia Donadello; Gustavo Büchele; Davide Simion; Maria-Luisa Chierego; Tatiana Oliveira Silva; Adriana Fonseca; Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2010-03-11       Impact factor: 17.440

8.  Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.

Authors:  Michael A Puskarich; Michael A Finkel; Alla Karnovsky; Alan E Jones; Julie Trexel; Brooke N Harris; Kathleen A Stringer
Journal:  Ann Am Thorac Soc       Date:  2015-01

9.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

10.  Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.